Company profile

HeartVista

Cardiology & Cardiovascular Health

Company profile

About HeartVista

Vista AI develops intelligent software to streamline and automate MRI examinations, making gold-standard imaging universally accessible. The company's flagship product, Vista AI Scan, is an FDA-cleared automated scanning platform that simplifies the image acquisition process, enabling technologists of all skill levels to perform accurate, high-quality cardiac MRI scans with consistency and efficiency. The platform addresses critical challenges facing imaging programs including rising demand, staffing shortages, and increasing clinical complexity. By automating what once required specialist expertise, Vista AI enables healthcare organizations to expand cardiac MRI services across multiple sites with existing staff and resources. The technology has demonstrated real-world results including 26% faster scan times, 50% more scan slots, and reduction of scan backlogs from 28 days to 1-day access. While initially focused on cardiac MRI—the most complex anatomy to image—Vista AI is rapidly expanding its automation platform to other anatomies including brain, prostate, and spine imaging. The company's vision is to make gold-standard MRI universally available through automation, ensuring every patient has access to high-quality imaging regardless of location or technologist expertise. Founded by Stanford-trained experts and guided by leading medical advisors, Vista AI serves health systems, imaging centers, and hospitals seeking to improve throughput, standardize quality, and expand access to advanced MRI services.

Company description HeartVista official website

Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at HeartVista?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cardiac conditions requiring MRI imaging
  • Expanding to brain, prostate, spine and other anatomical areas

Who it serves

  • Academic Medical Centers
  • Health Systems
  • Hospitals
  • Imaging Centers

Deployment & integration

Embedded · On Premise deployment with recorded integration context.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Two-year data release proving faster and more reliable MRI scans (December 2024), Daniel Hawkins appointed as CEO (March 2024), Steve Cashman joined Board of Directors (September 2023)

Partnerships

Recorded partners

  • Brigham and Women's Hospital
  • Radiology Regional
  • Stanford University
  • UCSF
  • University of Toronto Sunnybrook
  • University of Wisconsin
  • USC

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

RTHawk Research

MRI operating system and GUI-based design tools for research imaging applications

Platform · On PremiseCompany source

Vista AI Scan

FDA-cleared automated cardiac MRI scanning software for all technologists

Software · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

26% faster CMR scan times

Real-world cardiac MRI scanning efficiency

50% more scan slots

Increased throughput with existing resources

1-day CMR access from 28-day backlog

Reduced patient wait times for cardiac MRI

Brigham and Women's Hospital

Enhancing MRI workflow efficiency and technologist training for cardiac imaging

Faster scanning with greater confidence and consistency, quicker technologist training, reduced errors, increased productivity and patient access

Radiology Regional

Increasing access to high-quality cardiac MR imaging across community sites

Improved quality of cardiac MR imaging across the board

Stanford University

MRI research for catheter tracking and real-time analysis of movement

Sunnybrook Health Sciences Centre

MR-guided EP Ablation research

University of Wisconsin - Madison

MR-guided Convection Enhanced Delivery research

Unnamed Health System

Reducing cardiac MRI backlog and improving scan access

26% faster CMR scan times, 50% more scan slots, 1-day CMR access from a 28-day backlog

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Bob Hu

Chief Medical Officer & Co-Founder

LinkedIn

Juan Santos

Chief Architect and Head of Research & Co-Founder

LinkedIn

William Overall

Chief Technology Officer & Co-Founder

LinkedIn

Nicole Winokur

Vice President of Marketing

Sheila Saldana

Vice President of Client Success

06 · Company updates

Updates from HeartVista

Recent articles published on HeartVista's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Cardiology & Cardiovascular Health

Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon